Overall mortality in patients with a slow heart rate following myocardial infarction remains high despite the use of drugs such as atropine, steroids, and isoprenaline.
Does pharmacological treatment of slow heart rates improve mortality in patients following acute myocardial infarction?
Slow heart rates following acute myocardial infarction are associated with high mortality despite available pharmacological treatments.
. While ventricular fibrillation is the usual cause of sudden death, a frequent precursor appears to be a slow rate due to slow nodal rhythm or complete atrio-ventricular block (Brown et al., 1963), with a tendency to episodes of asystole or ventricular tachyarrhythmia. Despite the effectiveness of some drugs such as atropine, steroids, and isoprenaline, the over-all mortality in patients with a slow rate following myocardial infarction is high (Solarz, Berkson, and Pick, 1958; Gale and Enfroy, 1959;
Harris et al. (Thu,) conducted a other in Slow heart rates following acute myocardial infarction. Overall mortality in patients with a slow heart rate following myocardial infarction remains high despite the use of drugs such as atropine, steroids, and isoprenaline.